Panés, Julián <br/><br/>
Past, Present and Future of Therapeutic Interventions Targeting Leukocyte Trafficking in Inflammatory Bowel Disease.  [electronic resource] 

 -  Journal of Crohn's & colitis  Aug 2018 
 - S633-S640 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1876-4479 
<br/><br/><label>Standard No.: </label>10.1093/ecco-jcc/jjy011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Cell Adhesion Molecules<br/>Cell Communication--drug effects<br/>Chemotaxis, Leukocyte--drug effects<br/>Endothelial Cells--physiology<br/>Fingolimod Hydrochloride--therapeutic use<br/>Gastrointestinal Agents--pharmacology<br/>Gastrointestinal Tract--immunology<br/>Humans<br/>Immunoglobulins<br/>Immunosuppressive Agents--therapeutic use<br/>Indans--therapeutic use<br/>Inflammatory Bowel Diseases--drug therapy<br/>Integrins--antagonists & inhibitors<br/>Intercellular Adhesion Molecule-1<br/>Leukocytes--physiology<br/>Lysophospholipids--agonists<br/>Mucoproteins--antagonists & inhibitors<br/>Natalizumab--therapeutic use<br/>Oxadiazoles--therapeutic use<br/>Phosphorothioate Oligonucleotides--therapeutic use<br/>Receptors, Lysosphingolipid--agonists<br/>Sphingosine--agonists